AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (471.3 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Full Length Article | Open Access

Evaluation of DNA damage profile in obese women and its association to risk of metabolic syndrome, polycystic ovary syndrome and recurrent preeclampsia

Moushira Zakia,( ), Walaa Bashaa, Hala T. El-Bassyounib, Safinaz El-Toukhyc, Tamer Husseind
Biological Anthropology Department, Medical Research Division, National Research Centre, Cairo, Egypt
Clinical Genetics Department, National Research Centre, Cairo, Egypt
Medical Biochemistry Department, Medical Research Division, National Research Centre, Cairo, Egypt
Reproductive Health Research Department, Medical Research Division, National Research Centre, Cairo, Egypt

Peer review under responsibility of Chongqing Medical University.

Show Author Information

Abstract

Metabolic syndrome (MS) is a cluster of metabolic abnormalities. Obesity and MS are always accompanied by elevated oxidative stress which might affect cellular bio-molecules such as DNA. The aim of the present study is to investigate DNA damage profile in obese premenopausal women and its relation to the risk of MS, polycystic ovary syndrome (PCOS) and history of recurrent pre-eclampsia. The study included 90 obese women included cases with MS (n = 30), PCOS (n = 30) and previous history of recurrent preeclampsia (n = 30) and, age-matched healthy non-obese control women (n = 50). The assessment of leukocyte DNA damage was done by comet assay for all cases and controls. Anthropometry and biochemical parameters have been measured. Results showed that mean percent of DNA damage was significantly higher in MS, PCOS as well as in women with the recurrent preeclampsia as compared to healthy controls. The high level of mean DNA damage frequency in obese women was significantly associated with the increased number of metabolic syndrome components. Cases with 2, 3 and 3–5 components showed significantly higher levels of DNA damage than controls. Moreover, cases with 3–5 MS components showed significant higher DNA compared to those with the two components. Regarding PCOS, significant positive association between the mean frequency of DNA damage and waist circumference was observed. The study suggests that metabolic abnormalities, PCOS and recurrent pre-eclampsia might be contributed in development of DNA damage in obese women. DNA damage can serve as an early marker for obesity complications in premenopausal women.

Keywords

ObesityDNA damageMetabolic componentsPCOSRecurrent preeclampsia

References

1

Vassalle C, Maffei S, Ndreu R, Mercuri A. Age-related oxidative stress modulation by smoking habit and obesity. Clin Biochem. 2009;42(7):739-741.
Crossref Google Scholar
2

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553.
Crossref Google Scholar
3

Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34(6):416-422.
Crossref Google Scholar
4

Blaton VH, Korita I, Bulo A. How is metabolic syndrome related to dyslipidemia. Biochem Med. 2008;18(2):14-24.
Crossref Google Scholar
5

Alanbay I, Ercan CM, Sakinci M, Coksuer H, Ozturk M, Tapan S. A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity? Arch Gynecol Obstet. 2012;286(4):1065-1071.
Crossref Google Scholar
6

Kebapcilar AG, Tatar MG, Ipekci SH, et al. Cornea in PCOS patients as a possible target of IGF-1 action and insulin resistance. Arch Gynecol Obstet. 2014;290(6):1255-1263.
Crossref Google Scholar
7

Siti HN, Kamisah Y, Kamsiah J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol. 2015;71:40-56.
Crossref Google Scholar
8

Demirbag R, Yilmaz R, Gur M, et al. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int J Clin Pract. 2006;60(10):1187-1193.
Crossref Google Scholar
9

Bukhari SA, Rajoka MI, Nagra SA, Rehman ZU. Plasma homocysteine and DNA damage profiles in normal and obese subjects in the Pakistani population. Mol Biol Rep. 2010;37(1):289-295.
Crossref Google Scholar
10

Rytter E, Vessby B, Åsgård R, et al. Glycaemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes subjects. Br J Nutr. 2009;101(10):1423-1426.
Crossref Google Scholar
11

Moran LJ, Noakes M, Clifton PM, Norman RJ, Fenech MF. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat Res Mol Mech Mutagen. 2008;639(1):55-63.
Crossref Google Scholar
12

Harma M, Harma M, Erel O. Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol. 2005;118(1):47-51.
Crossref Google Scholar
13

Mert I, Sargın Oruc A, Yuksel S, et al. Role of oxidative stress in preeclampsia and intrauterine growth restriction. J Obstet Gynaecol Res. 2012;38(4):658-664.
Crossref Google Scholar
14

Andreassi MG. DNA damage, vascular senescence and atherosclerosis. J Mol Med. 2008;86(9):1033.
Crossref Google Scholar
15

Jonard S, Robert Y, Dewailly D. Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod. 2005;20(10):2893-2898.
Crossref Google Scholar
16

Williams L. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) final report. Circulation. 2002;106(25):3143.
Crossref Google Scholar
17

Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National cholesterol education Program versus World health organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio heart study. Circulation. 2004;110(10):1251-1257.
Crossref Google Scholar
18

Zaki M, Kamal S, Basha WA, et al. Assessment of DNA damage in obese premenopausal women with metabolic syndrome. Gene Rep. 2018;10:42-46.
Crossref Google Scholar
19

Tanner JM, Hiernaux J, Jarman S, Weiner JS, Lourie JA. Growth and physique studies. Hum Biol A Guid to F Methods IBP Handb. 1969;9:1-60.
Google Scholar
20

Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175(1):184-191.
Crossref Google Scholar
21

Arroyo-Johnson C, Mincey KD. Obesity epidemiology Worldwide. Gastroenterol Clin North Am. 2016;45(4):571-579.
Crossref Google Scholar
22

Ode KL, Frohnert BI, Nathan BM. Identification and treatment of metabolic complications in pediatric obesity. Rev Endocr Metab Disord. 2009;10(3):167-188.
Crossref Google Scholar
23

Scarpato R, Verola C, Fabiani B, Bianchi V, Saggese G, Federico G. Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the γ-H2AX focus assay and micronucleus test. FASEB J. 2011;25(2):685-693.
Crossref Google Scholar
24

Violante FS, Sanguinetti G, Barbieri A, et al. Lack of correlation between environmental or biological indicators of benzene exposure at parts per billion levels and micronuclei induction. Environ Res. 2003;91(3):135-142.
Crossref Google Scholar
25

Yesilada E, Sahin I, Ozcan H, Yildirim IH, Yologlu S, Taskapan C. Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome. Eur J Endocrinol. 2006;154(4):563-568.
Crossref Google Scholar
26

Giovannelli L, Saieva C, Masala G, et al. Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population. Carcinogenesis. 2002;23(9):1483-1489.
Crossref Google Scholar
27

Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163(4):427-436.
Crossref Google Scholar
28

Rani V, Deep G, Singh RK, Palle K, Yadav UCS. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183-193.
Crossref Google Scholar
29

Goodarzi MT, Navidi AA, Rezaei M, Babahmadi-Rezaei H. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. J Clin Lab Anal. 2010;24(2):72-76.
Crossref Google Scholar
30

Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP. Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health. 2012;12(1):380.
Crossref Google Scholar
31

Organization WH, WHO Multicentre Growth Reference Study Group. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva WHO.2006;2007.
Google Scholar
32

Qiao Q, Nyamdorj R. Is the association of type Ⅱ diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index? Eur J Clin Nutr. 2010;64(1):30-34.
Crossref Google Scholar
33

Esteghamati A, Mousavizadeh M, Noshad S, Shoar S, Khalilzadeh O, Nakhjavani M. Accuracy of anthropometric parameters in identification of high-risk patients predicted with cardiovascular risk models. Am J Med Sci. 2013;346(1):26-31.
Crossref Google Scholar
34

Shigenaga MK, Ames BN. Assays for 8-hydroxy-2′-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic Biol Med. 1991;10(3–4):211-216.
Crossref Google Scholar
35

Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.
Crossref Google Scholar
36

Fujimaki A, Watanabe K, Mori T, Kimura C, Shinohara K, Wakatsuki A. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction. Placenta. 2011;32(5):367-372.
Crossref Google Scholar
37

Hilali N, Kocyigit A, Demir M, et al. DNA damage and oxidative stress in patients with mild preeclampsia and offspring. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):377-380.
Crossref Google Scholar
38

Furness DLF, Dekker GA, Hague WM, Khong TY, Fenech MF. Increased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restriction. Mutagenesis. 2010;25(5):489-498.
Crossref Google Scholar
39

Wiktor H, Kankofer M, Schmerold I, Dadak A, Lopucki M, Niedermüller H. Oxidative DNA damage in placentas from normal and pre-eclamptic pregnancies. Virchows Arch. 2004;445(1):74-78.
Crossref Google Scholar
Genes & Diseases
Volume 5 Issue 4,
December 2018
Pages 367-373
DOI: 10.1016/j.gendis.2018.03.001
Cite this article:
Zaki M, Basha W, El-Bassyouni HT, et al. Evaluation of DNA damage profile in obese women and its association to risk of metabolic syndrome, polycystic ovary syndrome and recurrent preeclampsia. Genes & Diseases, 2018, 5(4): 367-373. https://doi.org/10.1016/j.gendis.2018.03.001

266

Views

3

Downloads

21

Crossref

N/A

Web of Science

24

Scopus

0

CSCD

Altmetrics
Received: 20 December 2017
Accepted: 03 March 2018
Published: 10 March 2018
© 2018, Chongqing Medical University.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return